Literature DB >> 6616425

Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program.

D L Morris, N O Borhani, E Fitzsimons, R J Hardy, C M Hawkins, J F Kraus, D R Labarthe, L Mastbaum, G H Payne.   

Abstract

The relation between serum cholesterol and cancer incidence was investigated in the population of the Hypertension Detection and Follow-up Program. During the 5 years of follow-up, 286 new cancer cases were documented among the 10,940 participants. Overall, age-adjusted cancer incidence rates, computed by baseline serum cholesterol quartiles, showed a small, but statistically significant, inverse relation between serum cholesterol and cancer incidence. No evidence suggested that the observed relationship was primarily due to confounding by other cancer risk factors, association of low serum cholesterol with incipient but undiagnosed cancer, or problems of competing risks. However, the relationship is weak and a causal interpretation of these immediate results cannot be argued persuasively. Examinations of specific cancer sites and factors related to serum cholesterol are suggested as important lines of research toward clarification of the complex relationships observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616425     DOI: 10.1002/1097-0142(19831101)52:9<1754::aid-cncr2820520933>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

Review 2.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

Review 3.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

4.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

5.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

6.  Association between plasma cholesterol and prostate cancer in the PSA era.

Authors:  Elizabeth A Platz; Steven K Clinton; Edward Giovannucci
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

7.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

8.  Are low cholesterol values associated with excess mortality?

Authors:  C E Salmond; R Beaglehole; I A Prior
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09

9.  Estimation of plasma lipids and its significance on histopathological grades in oral cancer: Prognostic significance an original research.

Authors:  Eugenia J Sherubin; Karthiga S Kannan; Dhineksh N Kumar; Isaac Joseph
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

10.  Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

Authors:  Susanne Strohmaier; Michael Edlinger; Jonas Manjer; Tanja Stocks; Tone Bjørge; Wegene Borena; Christel Häggström; Anders Engeland; Gabriele Nagel; Martin Almquist; Randi Selmer; Steinar Tretli; Hans Concin; Göran Hallmans; Håkan Jonsson; Pär Stattin; Hanno Ulmer
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.